(Total Views: 140)
Posted On: 04/17/2024 1:35:47 PM
Post# of 98

$CLDX News Article - Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria https://marketwirenews.com/news-releases/cell...57163.html


My Twitter: WhyteStocks